Related Experiment Video
Updated: Aug 13, 2025

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
Paula Cilleros-Holgado1, David Gómez-Fernández1, Rocío Piñero-Pérez1
1Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), 41013 Sevilla, Spain.
Abstract:
Mitochondrial dysfunction is a key pathological event in many diseases. Its role in energy production, calcium homeostasis, apoptosis regulation, and reactive oxygen species (ROS) balance render mitochondria essential for cell survival and fitness. However, there are no effective treatments for most primary and secondary mitochondrial diseases to this day. Therefore, new therapeutic approaches, such as the modulation of the mitochondrial unfolded protein response (mtUPR), are being explored. mtUPRs englobe several compensatory processes related to proteostasis and antioxidant system mechanisms. mtUPR activation, through an overcompensation for mild intracellular stress, promotes cell homeostasis and improves lifespan and disease alterations in biological models of mitochondrial dysfunction in age-related diseases, cardiopathies, metabolic disorders, and primary mitochondrial diseases. Although mtUPR activation is a promising therapeutic option for many pathological conditions, its activation could promote tumor progression in cancer patients, and its overactivation could lead to non-desired side effects, such as the increased heteroplasmy of mitochondrial DNA mutations. In this review, we present the most recent data about mtUPR modulation as a therapeutic approach, its role in diseases, and its potential negative consequences in specific pathological situations.
Insights
Modulating the mitochondrial unfolded protein response (mtUPR) offers a promising therapeutic strategy for mitochondrial dysfunction, improving cell health in various diseases. However, caution is advised due to potential risks in cancer and side effects from overactivation.
Area of Science:
- Mitochondrial Biology
- Cellular Stress Responses
- Therapeutic Strategies
Background:
- Mitochondrial dysfunction is central to numerous diseases, impacting energy production, calcium balance, apoptosis, and reactive oxygen species (ROS).
- Current treatments for primary and secondary mitochondrial diseases remain limited.
- The mitochondrial unfolded protein response (mtUPR) represents a novel therapeutic avenue.
Purpose of the Study:
- To review current data on mtUPR modulation as a therapeutic approach.
- To explore the role of mtUPR in various diseases.
- To discuss potential negative consequences of mtUPR activation.
Main Methods:
- Review of recent scientific literature on mtUPR.
- Analysis of mtUPR's role in cellular homeostasis and disease models.
- Evaluation of therapeutic potential and risks associated with mtUPR modulation.
Main Results:
- mtUPR activation promotes cell homeostasis and improves outcomes in models of mitochondrial dysfunction, age-related diseases, cardiopathies, metabolic disorders, and primary mitochondrial diseases.
- mtUPR activation may paradoxically promote tumor progression in cancer.
- Overactivation of mtUPR can lead to adverse effects, including increased mitochondrial DNA (mtDNA) heteroplasmy.
Conclusions:
- mtUPR modulation is a promising therapeutic strategy for mitochondrial dysfunction-related conditions.
- Careful consideration of mtUPR's dual role in disease and potential side effects is crucial for its clinical application.
- Further research is needed to optimize mtUPR-based therapies and mitigate risks.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Mitochondrial Precursor Proteins
Most of the mitochondrial...

